Fractionated Versus Single Dose Gemtuzumab Ozogamicin with Determinants of Benefit in Older AML: UK NCRI AML18 Trial.
Freeman SD. et al, (2023), Blood
Phenotypic screening identifies a trisubstituted imidazo[1,2-a]pyridine series that induces differentiation in multiple AML cell lines.
Josa-Culleré L. et al, (2023), Eur J Med Chem, 258
GTAC enables parallel genotyping of multiple genomic loci with chromatin accessibility profiling in single cells
Turkalj S. et al, (2023), Cell Stem Cell, 30, 722 - 740.e11
A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies.
Lachowiez CA. et al, (2023), Blood Cancer Discov
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study.
Sallman DA. et al, (2023), J Clin Oncol
Mutation agnostic diagnosis of clonal hematopoiesis of indeterminate potential (CHIP) using fluctuating methylation clocks
Schenck RO. et al, (2022), CANCER RESEARCH, 82
Color Atlas Of Clinical Hematology: Molecular and Cellular Basis of Disease
Hoffbrand AV. et al, (2018), 1 - 585
FIRST-IN-CLASS, ORAL MUTANT IDH2 INHIBITOR REVERSES DIFFERENTIATION BLOCK IN ACUTE MYELOID LEUKAEMIA TO PRODUCE CLINICALLY MEANINGFUL RESPONSES
Vyas P., (2017), EXPERIMENTAL HEMATOLOGY, 53, S38 - S38